Peeler Mary, Fiscella Kevin, Terplan Mishka, Sufrin Carolyn
1 The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
2 Family Medicine Research Programs, University of Rochester Medical Center, Rochester, NY, USA.
J Correct Health Care. 2019 Jan;25(1):4-14. doi: 10.1177/1078345818819855. Epub 2019 Jan 7.
Pregnant women represent a unique population for correctional facilities to care for. The incarcerated pregnant population is at an increased risk of concurrent opioid use disorder (OUD) that requires specialized care. The evidence-based best practice and standard of care for pregnant women with OUD is medication-assisted treatment (MAT) with methadone or buprenorphine pharmacotherapy. Correctional facilities that house women must be prepared to provide this care in a timely manner upon intake in order to address the serious medical needs of the pregnant woman and her fetus. Providing MAT in the incarceration setting has distinctive logistics that must be considered. This article recommends strategies to optimize the care of pregnant incarcerated women with OUD, emphasizing the importance of appropriate counseling and treatment with opioid agonist pharmacotherapy.
孕妇是惩教机构需要照料的特殊人群。被监禁的孕妇并发阿片类物质使用障碍（OUD）的风险增加，这需要专门护理。对于患有OUD的孕妇，基于证据的最佳实践和护理标准是使用美沙酮或丁丙诺啡药物疗法进行药物辅助治疗（MAT）。收容女性的惩教机构必须准备好在接收时及时提供这种护理，以满足孕妇及其胎儿的严重医疗需求。在监禁环境中提供MAT有独特的后勤问题必须加以考虑。本文推荐了优化对患有OUD的被监禁孕妇护理的策略，强调了适当咨询和使用阿片类激动剂药物疗法进行治疗的重要性。
